OHSU Study Determines Four Most Sensitive Objective Measures of Balance Dysfunction in Parkinson’s Disease

Using APDM’s Mobility Lab v2 and Opal IMU sensors, the study concludes that “these findings suggest that clinical trials focused on improving balance dysfunction in […]

To our loyal customers, We are happy to announce APDM’s acquisition by ERT, the leading data and technology company for clinical trials. Our companies’ operations […]

Objective To assess how postural sway deficits during eyes open and closed relate to the integrity of cerebellar peduncles in individuals with multiple sclerosis (MS). […]

Introduction Gait and balance impairments are cardinal features of Parkinson’s disease (PD) that require cognitive input. However, the extent to which specific gait and balance […]

Abstract Introduction: Impairment of dual-tasking, as an attention-based primary cognitive dysfunction, is frequently observed in Parkinson’s Disease (PD). The Training-PD study [...]

Neuromodulation is a non-invasive or minimally invasive therapy that has been gaining popularity for relieving symptoms and restoring function across a wide range of chronic […]

APDM in Attendance at the Society for Neuroscience Annual Conference San Diego, California Nov 3-7 Booth # 136   APDM Wearable Technologies is focused on […]

APDM in Attendance at the American Society of Neurorehabilitation Annual Conference San Diego, California Nov 1-2 Booth # 06   APDM Wearable Technologies is dedicated to […]

APDM in Attendance at the International Congress of Parkinson’s Disease & Movement Disorders Hong Kong Oct 5 -9 Booth # E05   APDM Wearable Technologies is […]

The number of older Americans aged 65 years or older will double to about 75 million during the next 25 years. This increase will have […]